Semin intervent Radiol 2019; 36(02): 126-132
DOI: 10.1055/s-0039-1688427
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Fibroid Expulsion after Uterine Artery Embolization

Emily Ochmanek
1   Division of Interventional Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado
,
Matthew A. Brown
1   Division of Interventional Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado
,
Paul J. Rochon
1   Division of Interventional Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
22 May 2019 (online)

Abstract

Uterine artery embolization (UAE) is a ubiquitous procedure, and a broadly recognized alternative to surgical interventions for symptomatic leiomyomata when uterine preservation is desired. Aside from postembolization syndrome (typically considered an expected feature of recovery), the most frequently described complications are temporary or permanent amenorrhea and lingering vaginal discharge. Less frequently described complications include fibroid expulsion (FE), protracted or refractory pain, infection, urinary retention, and access-related injuries. Reported rates of transcervical FE vary in the literature from 3 to 50% but are most often quoted to be around 5 to 15%. Certain features predispose a patient to FE, including size and location of the tumor, with pedunculated submucosal, submucosal, and transmural lesions considered to be “high risk.” While the optimal management of FE has not been definitively determined, high rates of nonoperative management of FE are noted in the literature. This article describes a case in which a fibroid was expulsed following UAE, as well as the management of the complication. A literature review and recommendations for the management of FE is also given.

Disclosure

The authors report no relevant financial disclosure.


 
  • References

  • 1 Dariushnia SR, Nikolic B, Stokes LS, Spies JB. ; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 2014; 25 (11) 1737-1747
  • 2 Hehenkamp WJK, Volkers NA, Donderwinkel PFJ. , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 2005; 193 (05) 1618-1629
  • 3 Shlansky-Goldberg RD, Coryell L, Stavropoulos SW. , et al. Outcomes following fibroid expulsion after uterine artery embolization. J Vasc Interv Radiol 2011; 22 (11) 1586-1593
  • 4 Verma SK, Bergin D, Gonsalves CF, Mitchell DG, Lev-Toaff AS, Parker L. Submucosal fibroids becoming endocavitary following uterine artery embolization: risk assessment by MRI. AJR Am J Roentgenol 2008; 190 (05) 1220-1226
  • 5 Caplin DM, Nikolic B, Kalva SP, Ganguli S, Saad WEA, Zuckerman DA. ; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 2011; 22 (11) 1499-1506
  • 6 Ten Cate-Hoek AJ. Prevention and treatment of the post-thrombotic syndrome. Res Pract Thromb Haemost 2018; 2 (02) 209-219
  • 7 Craig P, Zuchowski A, Young S, Golzarian J, Rosenberg M. Results of endovascular management of May-Thurner syndrome in the acute, subacute, and chronic setting. J Vasc Interv Radiol 2017; 28 (02) S113
  • 8 Garcia M, Sterling K, Jaff M. , et al. ACCESS PTS Study: accelerated thrombolysis for post-thrombotic syndrome using the acoustic pulse thrombolysis EkoSonic endovascular system: midterm results of a multicenter study. J Vasc Interv Radiol 2018; 29 (04) S151